These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32316993)

  • 1. Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB).
    Reza TF; Nalugwa T; Farr K; Nantale M; Oyuku D; Nakaweesa A; Musinguzi J; Vangala M; Shete PB; Tucker A; Ferguson O; Fielding K; Sohn H; Dowdy D; Moore DAJ; Davis JL; Ackerman SL; Handley MA; Katamba A; Cattamanchi A
    Implement Sci; 2020 Apr; 15(1):24. PubMed ID: 32316993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis.
    Thompson RR; Nalugwa T; Oyuku D; Tucker A; Nantale M; Nakaweesa A; Musinguzi J; Reza TF; Zimmer AJ; Ferguson O; Turyahabwe S; Joloba M; Cattamanchi A; Katamba A; Dowdy DW; Sohn H
    Lancet Glob Health; 2023 Feb; 11(2):e278-e286. PubMed ID: 36669808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE).
    Leukes VN; Hella J; Sabi I; Cossa M; Khosa C; Erkosar B; Mangu C; Siyame E; Mtafya B; Lwilla A; Viegas S; Madeira C; Machiana A; Ribeiro J; Garcia-Basteiro AL; Riess F; Elísio D; Sasamalo M; Mhalu G; Denkinger CM; Castro MDM; Bashir S; Schumacher SG; Tagliani E; Malhotra A; Dowdy D; Schacht C; Buech J; Nguenha D; Ntinginya N; Ruhwald M; Penn-Nicholson A; Kranzer K;
    BMC Infect Dis; 2024 Jan; 24(1):107. PubMed ID: 38243223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
    Cattamanchi A; Reza TF; Nalugwa T; Adams K; Nantale M; Oyuku D; Nabwire S; Babirye D; Turyahabwe S; Tucker A; Sohn H; Ferguson O; Thompson R; Shete PB; Handley MA; Ackerman S; Joloba M; Moore DAJ; Davis JL; Dowdy DW; Fielding K; Katamba A
    N Engl J Med; 2021 Dec; 385(26):2441-2450. PubMed ID: 34936740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective.
    Nalugwa T; Shete PB; Nantale M; Farr K; Ojok C; Ochom E; Mugabe F; Joloba M; Dowdy DW; Moore DAJ; Davis JL; Cattamanchi A; Katamba A
    BMC Health Serv Res; 2020 Mar; 20(1):162. PubMed ID: 32131814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial.
    Gupta-Wright A; Fielding KL; van Oosterhout JJ; Wilson DK; Corbett EL; Flach C; Reddy KP; Walensky RP; Peters JA; Alufandika-Moyo M; Lawn SD
    BMC Infect Dis; 2016 Sep; 16(1):501. PubMed ID: 27659507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda.
    Byanyima P; Kaswabuli S; Musisi E; Nabakiibi C; Zawedde J; Sanyu I; Sessolo A; Andama A; Worodria W; Huang L; Davis JL
    Microbiol Spectr; 2022 Oct; 10(5):e0086022. PubMed ID: 36154664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
    Di Tanna GL; Khaki AR; Theron G; McCarthy K; Cox H; Mupfumi L; Trajman A; Zijenah LS; Mason P; Bandason T; Durovni B; Bara W; Hoelscher M; Clowes P; Mangu C; Chanda D; Pym A; Mwaba P; Cobelens F; Nicol MP; Dheda K; Churchyard G; Fielding K; Metcalfe JZ
    Lancet Glob Health; 2019 Feb; 7(2):e191-e199. PubMed ID: 30683238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
    Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
    PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial.
    Vessière A; Font H; Gabillard D; Adonis-Koffi L; Borand L; Chabala C; Khosa C; Mavale S; Moh R; Mulenga V; Mwanga-Amumpere J; Taguebue JV; Eang MT; Delacourt C; Seddon JA; Lounnas M; Godreuil S; Wobudeya E; Bonnet M; Marcy O
    BMC Pediatr; 2021 Mar; 21(1):136. PubMed ID: 33743621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.
    Auld AF; Agizew T; Pals S; Finlay A; Ndwapi N; Boyd R; Alexander H; Mathoma A; Basotli J; Gwebe-Nyirenda S; Shepherd J; Ellerbrock TV; Date A
    BMC Infect Dis; 2016 Oct; 16(1):606. PubMed ID: 27782821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
    Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
    PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda.
    Andama A; Jaganath D; Crowder R; Asege L; Nakaye M; Katumba D; Mukwatamundu J; Mwebe S; Semitala CF; Worodria W; Joloba M; Mohanty S; Somoskovi A; Cattamanchi A
    BMC Infect Dis; 2021 Jan; 21(1):49. PubMed ID: 33430790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and Operational Research: What Happens After a Negative Test for Tuberculosis? Evaluating Adherence to TB Diagnostic Algorithms in South African Primary Health Clinics.
    McCarthy KM; Grant AD; Chihota V; Ginindza S; Mvusi L; Churchyard GJ; Fielding KL
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):e119-26. PubMed ID: 26966843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
    Haraka F; Kakolwa M; Schumacher SG; Nathavitharana RR; Denkinger CM; Gagneux S; Reither K; Ross A
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012972. PubMed ID: 34097769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.